Class Action Lawsuit Filed Against Atara Biotherapeutics and Certain Officers

A class action lawsuit has been filed against Atara Biotherapeutics, Inc. (NASDAQ: ATRA) and certain officers, alleging violations of federal securities laws. The lawsuit seeks damages for investors who purchased Atara securities between May 20, 2024, and January 9, 2026. The case is being handled by Pomerantz LLP in the United States District Court for the Central District of California.

By Pomerantz LLP · PR Newswire · April 16, 2026, 14:00 UTC

Tickers: $ATRA

Topics: Atara Biotherapeutics class action lawsuit NASDAQ: ATRA Pomerantz LLP securities fraud

Read the full article at PR Newswire

More World news

Standard Nuclear Reports $577.2 Million Contract Backlog and Targets 2027 DOE Authorization Seeking Alpha · November 12, 2026, 18:10 UTC
Nuwellis Reports Q3 2026 Revenue of $2.2 Million and Improved Operating Loss Motley Fool · November 12, 2026, 18:09 UTC
Nebius Group Reports Strong Revenue Growth Amidst Capacity Delays and Increased Capital Expenditure Motley Fool · November 12, 2026, 18:11 UTC
Pelagos Insurance Reports Q3 2026 Earnings with Increased Gross Premiums Written Motley Fool · November 12, 2026, 18:11 UTC
Sprott Physical Gold Trust USD Reports Q3 Net Income of $508.82 Million Seeking Alpha · November 12, 2026, 18:07 UTC
NYSE Gains $500 Billion in Market Capitalization via Nine Major Listing Transfers PR Newswire · November 12, 2026, 18:05 UTC
PenFed Foundation Grants $25,000 to Northern Virginia Vietnam Veterans Foundation PR Newswire · November 12, 2026, 18:06 UTC
Allstate Announces Quarterly Dividend of $1.08 Per Share Seeking Alpha · November 12, 2026, 18:01 UTC
Pinnacle Bankshares Increases Quarterly Dividend to $0.35 Per Share Seeking Alpha · November 12, 2026, 18:02 UTC
Avidbank Reports Third Quarter 2026 Earnings Growth Driven by Core Deposits and C&I Lending Motley Fool · November 12, 2026, 18:00 UTC